Table 3.
Cox multivariate models
| Variables | Disease‐specific survival | ||
|---|---|---|---|
| HR | 95% CI | P‐values | |
| Model 1 | |||
| Stage (T2‐T4) | 2.221 | 0.979–5.040 | 0.056 |
| Grade (G2‐G3) | 1.679 | 0.711–3.962 | 0.237 |
| MMP‐7 serum (>7.15 ng/mL) | 1.953 | 1.027–3.712 | 0.041 |
| Model 2 | |||
| Stage (T2‐T4) | 2.595 | 1.035–6.508 | 0.042 |
| Grade (G2‐G3) | 2.557 | 1.089–6.008 | 0.031 |
| MMP‐7 expression (>63 rel.exp.) | 1.885 | 1.00–3.551 | 0.050 |
| Variables | Metastasis‐free survival | ||
|---|---|---|---|
| HR | 95% CI | P‐values | |
| Model 3 | |||
| Stage (T2‐T4) | 1.323 | 0.430–4.075 | 0.626 |
| Grade (G3) | 3.699 | 0.859–15.926 | 0.079 |
| MMP‐7 serum (>7.15 ng/mL) | 2.534 | 1.008–6.373 | 0.048 |
| Model 4 | |||
| Stage (T2‐T4) | 7.427 | 1.521–36.258 | 0.013 |
| Grade (G3) | 1.035 | 0.272–3.933 | 0.960 |
| MMP‐7 expression (>63 rel.exp.) | 3.804 | 1.288–11.229 | 0.016 |
CI, confidence interval; HR, hazard ratio.